# Tamboran Resources Corp: financial statements, quarterly

TBN · NYSE · CIK 1997652 · [Energy](/sectors/energy.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/tbn.md) · [Financials](/companies/tbn/financials.md) · [Filings](/companies/tbn/filings.md) · [Insiders](/companies/tbn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tbn/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001997652-24-000002.md) | [0.0](/filings/0001628280-25-005147.md) | [0.0](/filings/0001628280-25-025261.md) | [0.0 d](/filings/0001628280-25-042774.md) | [0.0](/filings/0001628280-25-052026.md) | [0.0](/filings/0001628280-26-007263.md) | [0.0](/filings/0001628280-26-034593.md) | [0.0 d](/filings/0001628280-26-063492.md) | [0.0](/filings/0001628280-25-052026.md) | [0.0](/filings/0001628280-26-007263.md) | [0.0](/filings/0001628280-26-034593.md) | [0.0 d](/filings/0001628280-26-063492.md) |
| Research and development | $m | not reported | [0.0](/filings/0001628280-25-005147.md) | [0.0](/filings/0001628280-25-025261.md) | [0.0 d](/filings/0001628280-25-042774.md) | [0.0](/filings/0001628280-25-052026.md) | [3.2](/filings/0001628280-26-007263.md) | [2.0](/filings/0001628280-26-034593.md) | [0.8 d](/filings/0001628280-26-063492.md) | [0.2](/filings/0001628280-25-052026.md) | [0.1](/filings/0001628280-26-007263.md) | [0.0](/filings/0001628280-26-034593.md) | [(0.2) d](/filings/0001628280-26-063492.md) |
| Operating income | $m | [(4.3)](/filings/0001997652-24-000002.md) | [(6.7)](/filings/0001628280-25-005147.md) | [(3.6)](/filings/0001628280-25-025261.md) | [(5.9) d](/filings/0001628280-25-042774.md) | [(7.0)](/filings/0001628280-25-052026.md) | [(15.0)](/filings/0001628280-26-007263.md) | [(8.8)](/filings/0001628280-26-034593.md) | [(8.5) d](/filings/0001628280-26-063492.md) | [(8.2)](/filings/0001628280-25-052026.md) | [(7.8)](/filings/0001628280-26-007263.md) | [(8.4)](/filings/0001628280-26-034593.md) | [(8.3) d](/filings/0001628280-26-063492.md) |
| Net income | $m | [(3.2)](/filings/0001997652-24-000002.md) | [(6.0)](/filings/0001628280-25-005147.md) | [(3.3)](/filings/0001628280-25-025261.md) | [(9.4) d](/filings/0001628280-25-042774.md) | [(5.9)](/filings/0001628280-25-052026.md) | [(14.2)](/filings/0001628280-26-007263.md) | [(6.7)](/filings/0001628280-26-034593.md) | [(10.2) d](/filings/0001628280-26-063492.md) | [(8.2)](/filings/0001628280-25-052026.md) | [(6.6)](/filings/0001628280-26-007263.md) | [(9.4)](/filings/0001628280-26-034593.md) | [(1.9) d](/filings/0001628280-26-063492.md) |
| Diluted EPS | $ per share | [(0.38)](/filings/0001997652-24-000002.md) | [(0.69)](/filings/0001628280-25-005147.md) | [(0.32)](/filings/0001628280-25-025261.md) | not reported | [(0.42)](/filings/0001628280-25-052026.md) | [(0.99)](/filings/0001628280-26-007263.md) | [(0.46)](/filings/0001628280-26-034593.md) | not reported | [(0.47)](/filings/0001628280-25-052026.md) | [(0.33)](/filings/0001628280-26-007263.md) | [(0.42)](/filings/0001628280-26-034593.md) | not reported |
| Basic EPS | $ per share | [(0.38)](/filings/0001997652-24-000002.md) | [(0.69)](/filings/0001628280-25-005147.md) | [(0.32)](/filings/0001628280-25-025261.md) | not reported | [(0.42)](/filings/0001628280-25-052026.md) | [(0.99)](/filings/0001628280-26-007263.md) | [(0.46)](/filings/0001628280-26-034593.md) | not reported | [(0.47)](/filings/0001628280-25-052026.md) | [(0.33)](/filings/0001628280-26-007263.md) | [(0.42)](/filings/0001628280-26-034593.md) | not reported |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [74.7](/filings/0001628280-25-042774.md) | [74.0](/filings/0001997652-24-000002.md) | [59.4](/filings/0001628280-25-005147.md) | [25.6](/filings/0001628280-25-025261.md) | [39.4](/filings/0001628280-26-063492.md) | [39.6](/filings/0001628280-25-052026.md) | [83.4](/filings/0001628280-26-007263.md) | [88.2](/filings/0001628280-26-034593.md) | [219](/filings/0001628280-26-063492.md) |
| Current assets | $m | not reported | not reported | not reported | [97.3](/filings/0001628280-25-042774.md) | [90.0](/filings/0001997652-24-000002.md) | [67.3](/filings/0001628280-25-005147.md) | [37.9](/filings/0001628280-25-025261.md) | [56.7](/filings/0001628280-26-063492.md) | [46.5](/filings/0001628280-25-052026.md) | [106](/filings/0001628280-26-007263.md) | [118](/filings/0001628280-26-034593.md) | [243](/filings/0001628280-26-063492.md) |
| Total assets | $m | not reported | not reported | not reported | [359](/filings/0001628280-25-042774.md) | [381](/filings/0001997652-24-000002.md) | [363](/filings/0001628280-25-005147.md) | [382](/filings/0001628280-25-025261.md) | [446](/filings/0001628280-26-063492.md) | [484](/filings/0001628280-25-052026.md) | [601](/filings/0001628280-26-007263.md) | [672](/filings/0001628280-26-034593.md) | [1,154](/filings/0001628280-26-063492.md) |
| Current liabilities | $m | not reported | not reported | not reported | [28.0](/filings/0001628280-25-042774.md) | [34.7](/filings/0001997652-24-000002.md) | [38.1](/filings/0001628280-25-005147.md) | [34.4](/filings/0001628280-25-025261.md) | [36.6](/filings/0001628280-26-063492.md) | [50.3](/filings/0001628280-25-052026.md) | [53.0](/filings/0001628280-26-007263.md) | [59.1](/filings/0001628280-26-034593.md) | [93.1](/filings/0001628280-26-063492.md) |
| Total liabilities | $m | not reported | not reported | not reported | [51.0](/filings/0001628280-25-042774.md) | [54.2](/filings/0001997652-24-000002.md) | [53.9](/filings/0001628280-25-005147.md) | [56.2](/filings/0001628280-25-025261.md) | [57.0](/filings/0001628280-26-063492.md) | [68.8](/filings/0001628280-25-052026.md) | [110](/filings/0001628280-26-007263.md) | [125](/filings/0001628280-26-034593.md) | [184](/filings/0001628280-26-063492.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-007263.md) | not reported | [0.0](/filings/0001628280-26-063492.md) | not reported | [32.6](/filings/0001628280-26-007263.md) | [44.6](/filings/0001628280-26-034593.md) | [59.0](/filings/0001628280-26-063492.md) |
| Shareholders' equity | $m | [192](/filings/0001628280-25-025261.md) | [228](/filings/0001628280-25-025261.md) | [228](/filings/0001628280-25-025261.md) | [263](/filings/0001628280-25-042774.md) | [276](/filings/0001997652-24-000002.md) | [244](/filings/0001628280-25-005147.md) | [240](/filings/0001628280-25-025261.md) | [288](/filings/0001628280-26-063492.md) | [295](/filings/0001628280-25-052026.md) | [359](/filings/0001628280-26-007263.md) | [396](/filings/0001628280-26-034593.md) | [796](/filings/0001628280-26-063492.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.3)](/filings/0001997652-24-000002.md) | [(7.1) d](/filings/0001628280-25-005147.md) | [(0.0) d](/filings/0001628280-25-025261.md) | [(0.9) d](/filings/0001628280-25-042774.md) | [(4.2)](/filings/0001628280-25-052026.md) | [(4.7) d](/filings/0001628280-26-007263.md) | [(14.3) d](/filings/0001628280-26-034593.md) | [(6.4) d](/filings/0001628280-26-063492.md) | [(13.8)](/filings/0001628280-25-052026.md) | [(0.7) d](/filings/0001628280-26-007263.md) | [(12.5) d](/filings/0001628280-26-034593.md) | [(7.6) d](/filings/0001628280-26-063492.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8.5](/filings/0001997652-24-000002.md) | [8.7](/filings/0001628280-25-005147.md) | [10.2](/filings/0001628280-25-025261.md) | [14.1](/filings/0001628280-25-052026.md) | [14.3](/filings/0001628280-26-007263.md) | [14.5](/filings/0001628280-26-034593.md) | [17.5](/filings/0001628280-25-052026.md) | [20.0](/filings/0001628280-26-007263.md) | [22.4](/filings/0001628280-26-034593.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,960,006 at 2026-09-23, from the cover of the [10-K filed 2026-09-25](/filings/0001628280-26-063492.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.